JENNY STEBEN: Open Payments
NPI 1962134536 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 4 payments from 3 companies in 2025. Trend: 2023 $430 · 2024 $500 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 1 | $174 |
| MDD US Operations, LLC | 2 | $39 |
| Novo Nordisk Inc | 1 | $16 |
Products named: DAXXIFY, Qelbree, Ozempic.
Industry payments across IA — which companies pay providers there.
